Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Eli Lilly (LLY) files lawsuit against U.S. health agency over 340B Program rebates, alleging arbitrary blockage of its cash ...

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...

Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

By Samuel Indyk and Ludwig Burger (Reuters) -Shares in global vaccine makers and drugmakers fell on Friday after U.S.

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's ...

Lilly filed a lawsuit Nov. 14 against HHS head Xavier Becerra and the Health Resources and Services Administration for blocking a plan to change its 340B program from immediate discounts to offering ...

Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program ...